GDNF and Parkinson disease: Since the fusion protein is 17% GDNF and 83% HIRMAb, this dose of the fusion protein is equal to 22 ug of GDNF, and is comparable to the dose of GDNF that is neuroprotective following intra-cerebral injection in the rat with experimental PD (Sullivan et al., 1998).